InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2021

NEXT STORY
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
PREV STORY
FibroGen Reports Third Quarter 2021 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Phase 2 data of selatogrel, Idorsia’s highly-selective P2Y12 receptor antagonist, presented at ESC 2019

author_avatar
NASDAQ Market News

ChemoCentryx Reports Third Quarter 2020 Financial Results and Recent Highlights

author_avatar
NASDAQ Market News

Oncology Venture ingår samarbeten med ledande tyska och danska läkarnätverk och etablerar laboratorium i Berlin för att utveckla precisionsmedicin mot cancer

author_avatar
NASDAQ Market News